Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Identification of PARP14 inhibitors using novel methods for detecting auto-ribosylation.
Biochem Biophys Res Commun. 2017 May 6;486(3):626-631. doi: 10.1016/j.bbrc.2017.03.052. Epub 2017 Mar 14.
Biochem Biophys Res Commun. 2017.
PMID: 28315326
Free article.
High-Throughput Screening to Identify Inhibitors of DEAD Box Helicase DDX41.
Yoneyama-Hirozane M, Kondo M, Matsumoto SI, Morikawa-Oki A, Morishita D, Nakanishi A, Kawamoto T, Nakayama M.
Yoneyama-Hirozane M, et al.
SLAS Discov. 2017 Oct;22(9):1084-1092. doi: 10.1177/2472555217705952. Epub 2017 Apr 20.
SLAS Discov. 2017.
PMID: 28426938
Free article.
Item in Clipboard
Identification and Characterization of a New Series of Ghrelin O-Acyl Transferase Inhibitors.
Yoneyama-Hirozane M, Deguchi K, Hirakawa T, Ishii T, Odani T, Matsui J, Nakano Y, Imahashi K, Takakura N, Chisaki I, Takekawa S, Sakamoto J.
Yoneyama-Hirozane M, et al.
SLAS Discov. 2018 Feb;23(2):154-163. doi: 10.1177/2472555217727097. Epub 2017 Aug 28.
SLAS Discov. 2018.
PMID: 28846466
Free article.
Item in Clipboard
Discovery of TAK-925 as a Potent, Selective, and Brain-Penetrant Orexin 2 Receptor Agonist.
Fujimoto T, Rikimaru K, Fukuda K, Sugimoto H, Masuda K, Ohyabu N, Banno Y, Tokunaga N, Kawamoto T, Tomata Y, Kumagai Y, Iida M, Nagano Y, Yoneyama-Hirozane M, Shimizu Y, Sasa K, Ishikawa T, Yukitake H, Ito M, Aoyama K, Matsumoto T.
Fujimoto T, et al. Among authors: yoneyama hirozane m.
ACS Med Chem Lett. 2022 Feb 4;13(3):457-462. doi: 10.1021/acsmedchemlett.1c00626. eCollection 2022 Mar 10.
ACS Med Chem Lett. 2022.
PMID: 35295087
Free PMC article.
Item in Clipboard
Antiobesity and emetic effects of a short-length peptide YY analog and its PEGylated and alkylated derivatives.
Niida A, Kanematsu-Yamaki Y, Asakawa T, Ishimura Y, Fujita H, Matsumiya K, Nishizawa N, Adachi Y, Mochida T, Tsuchimori K, Yoneyama-Hirozane M, Sakamoto J, Hirabayashi H, Fukui H, Takekawa S, Asami T.
Niida A, et al. Among authors: yoneyama hirozane m.
Bioorg Med Chem. 2018 Feb 1;26(3):566-572. doi: 10.1016/j.bmc.2017.12.014. Epub 2017 Dec 8.
Bioorg Med Chem. 2018.
PMID: 29279243
Item in Clipboard
Health-related quality of life in health states corresponding to different stages of perianal fistula associated with Crohn's disease: a quantitative evaluation of patients and non-patients in Japan.
Kato M, Yoneyama-Hirozane M, Iwasaki K, Matsubayashi M, Igarashi A.
Kato M, et al. Among authors: yoneyama hirozane m.
J Mark Access Health Policy. 2023 Jan 15;11(1):2166374. doi: 10.1080/20016689.2023.2166374. eCollection 2023.
J Mark Access Health Policy. 2023.
PMID: 36684854
Free PMC article.
Item in Clipboard
Public preferences and willingness to accept a hypothetical vaccine to prevent a pandemic in Japan: a conjoint analysis.
Igarashi A, Nakano Y, Yoneyama-Hirozane M.
Igarashi A, et al. Among authors: yoneyama hirozane m.
Expert Rev Vaccines. 2022 Feb;21(2):241-248. doi: 10.1080/14760584.2022.2016402. Epub 2022 Jan 24.
Expert Rev Vaccines. 2022.
PMID: 35073824
Item in Clipboard
Willingness to pay for QALY: perspectives and contexts in Japan.
Igarashi A, Goto R, Yoneyama-Hirozane M.
Igarashi A, et al. Among authors: yoneyama hirozane m.
J Med Econ. 2019 Oct;22(10):1041-1046. doi: 10.1080/13696998.2019.1639186. Epub 2019 Aug 6.
J Med Econ. 2019.
PMID: 31262236
Free article.
Item in Clipboard
Cite
Cite